| P2093 | author name string | Samapika Routray | |
| P2860 | cites work | The tumour microenvironment as a target for chemoprevention. | Q53338021 |
| | Effect of Synthetic Sialyl 2→1 Sphingosine and Other Glycosylsphingosines on the Structure and Function of the “Glycosphingolipid Signaling Domain (GSD)” in Mouse Melanoma B16 Cells† | Q57365131 |
| | Caveolin and Cancer | Q57375572 |
| | Cell-specific targeting of caveolin-1 to caveolae, secretory vesicles, cytoplasm or mitochondria | Q73635492 |
| | Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice | Q73738455 |
| | Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells | Q74392346 |
| | Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells | Q77604359 |
| | Caveolin-1 functions as a scaffolding protein for phosphofructokinase in the metabolic organization of vascular smooth muscle | Q81173842 |
| | Expression of caveolin-1 in lymphocytes induces caveolae formation and recruitment of phosphofructokinase to the plasma membrane | Q81306474 |
| | The association of Caveolin-1 genotypes with oral cancer susceptibility in Taiwan | Q83234081 |
| | Expression of Cav-1 in tumour cells, rather than in stromal tissue, may promote cervical squamous cell carcinoma proliferation, and correlates with high-risk HPV infection | Q83541166 |
| | The caveolin proteins | Q21194854 |
| | Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette | Q24290507 |
| | Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment | Q24611183 |
| | Understanding the "lethal" drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environment | Q24620228 |
| | An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers | Q24658358 |
| | On the Origin of Cancer Cells | Q27861025 |
| | Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains | Q28114920 |
| | TIGAR, a p53-inducible regulator of glycolysis and apoptosis | Q28118306 |
| | Lipid rafts and signal transduction | Q28131735 |
| | Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor | Q28139202 |
| | Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer | Q28247646 |
| | Good cop, bad cop: the different faces of NF-kappaB | Q28291669 |
| | Evidence for a regulated interaction between heterotrimeric G proteins and caveolin | Q28304271 |
| | Caveolin-1 and regulation of cellular cholesterol homeostasis | Q28590709 |
| | Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice | Q29615180 |
| | Structure of caveolae | Q33224886 |
| | An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation | Q34082390 |
| | Multidrug resistance: a role for cholesterol efflux pathways? | Q34085592 |
| | Caveolin 1 protein expression in renal cell carcinoma predicts survival | Q34094723 |
| | Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis | Q34377138 |
| | Caveolins and caveolae: molecular and functional relationships. | Q34430534 |
| | The fine structure of the gall bladder epithelium of the mouse. | Q34537858 |
| | Hydrogen peroxide inhibits non-small cell lung cancer cell anoikis through the inhibition of caveolin-1 degradation | Q34597628 |
| | Caveolae: from cell biology to animal physiology | Q34838611 |
| | The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma | Q35013613 |
| | The two faces of transforming growth factor beta in carcinogenesis | Q35170231 |
| | Expression of caveolin-1 in tongue squamous cell carcinoma by quantum dots | Q35197219 |
| | Caveolin-1 in oncogenic transformation, cancer, and metastasis | Q36030347 |
| | Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers | Q36105188 |
| | Signalling hypoxia by HIF hydroxylases | Q36247647 |
| | Relationship of hypoxia to metastatic ability in rodent tumours | Q36622970 |
| | Role of caveolin-1 in the regulation of lipoprotein metabolism | Q36805369 |
| | Caveolin-1 modulates the ability of Ewing's sarcoma to metastasize. | Q36921347 |
| | Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma. | Q36977578 |
| | Effect of simvastatin on glioma cell proliferation, migration, and apoptosis | Q37011538 |
| | Dissecting lipid raft facilitated cell signaling pathways in cancer | Q37047889 |
| | Caveolin-1 in cell polarization and directional migration | Q37122481 |
| | Caveolin-1 in tumor progression: the good, the bad and the ugly. | Q37174457 |
| | A novel orthotopic mouse model of head and neck cancer and lymph node metastasis | Q37275756 |
| | Exploring the caves: cavins, caveolins and caveolae. | Q37691898 |
| | Caveolin-1 in sarcomas: friend or foe? | Q37862525 |
| | Lipid rafts: signaling and sorting platforms of cells and their roles in cancer | Q37866316 |
| | Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms | Q37955237 |
| | Caveolin involvement and modulation in breast cancer | Q37986917 |
| | Role for membrane remodeling in cell death: implication for health and disease. | Q38071468 |
| | Prognostic role of caveolin in breast cancer: a meta-analysis | Q38103676 |
| | Caveolin-1 promotes gastric cancer progression by up-regulating epithelial to mesenchymal transition by crosstalk of signalling mechanisms under hypoxic condition | Q39091264 |
| | Caveolin-1 interacts with protein phosphatase 5 and modulates its activity in prostate cancer cells. | Q39204403 |
| | Caveolin-1 overexpression is associated with simultaneous abnormal expression of the E-cadherin/α-β catenins complex and multiple ErbB receptors and with lymph nodes metastasis in head and neck squamous cell carcinomas | Q39418467 |
| | Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma | Q39627176 |
| | Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors | Q39690774 |
| | The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts | Q39701172 |
| | Caveolin-1 tumor-promoting role in human melanoma | Q39838942 |
| | Differential expression and function of caveolin-1 in human gastric cancer progression | Q40079568 |
| | Binding of nuclear caveolin-1 to promoter elements of growth-associated genes in ovarian carcinoma cells. | Q40159262 |
| | Expression of caveolin-1 and its correlation with cisplatin sensitivity in oral squamous cell carcinoma | Q40430236 |
| | Caveolin-1 is required for vascular endothelial growth factor-triggered multiple myeloma cell migration and is targeted by bortezomib | Q40502610 |
| | Mutation and aberrant expression of Caveolin-1 in human oral squamous cell carcinomas and oral cancer cell lines. | Q40599924 |
| | Caveolin-1 binding to endoplasmic reticulum membranes and entry into the regulated secretory pathway are regulated by serine phosphorylation. Protein sorting at the level of the endoplasmic reticulum | Q40842538 |
| | Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation. | Q40842780 |
| | Identification of caveolin-1 in lipoprotein particles secreted by exocrine cells | Q40916872 |
| | Characterization of a cytosolic heat-shock protein-caveolin chaperone complex. Involvement in cholesterol trafficking | Q41052229 |
| | The absence of caveolin-1 increases proliferation and anchorage- independent growth by a Rac-dependent, Erk-independent mechanism. | Q42546542 |
| | Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells | Q44249820 |
| | c-Abl is required for oxidative stress-induced phosphorylation of caveolin-1 on tyrosine 14. | Q44280640 |
| | The biphasic differential expression of the cellular membrane protein, caveolin-1, in oral carcinogenesis | Q44538913 |
| | Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus | Q45846975 |
| | Differential caveolin-1 expression in colon carcinoma and its relation to E-cadherin-β-catenin complex. | Q50855955 |
| | Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. | Q52552851 |
| P433 | issue | 10 | |
| P921 | main subject | oral squamous cell carcinoma | Q18553522 |
| P304 | page(s) | 9487-9495 | |
| P577 | publication date | 2014-08-16 | |
| P1433 | published in | Tumor Biology | Q15757842 |
| P1476 | title | Caveolin-1 in oral squamous cell carcinoma microenvironment: an overview | |
| P478 | volume | 35 | |